Background
Patients with recovery of left ventricular ejection fraction (LVEF) remain at risk for future deterioration of LVEF. However, there are no tools to risk stratify these patients. We hypothesized that global longitudinal strain could predict sustained recovery within this population.
Methods and Results
We retrospectively identified 96 patients with a reduced LVEF < 50% (screening echocardiogram), whose LVEF had increased by at least 10 % and normalized (>50%) on evidence based medical therapies (baseline echocardiogram). We examined absolute global longitudinal strain (GLS) on the baseline echocardiogram in relation to changes in LVEF on a follow-up echocardiogram. Patients with recovered LVEF had a wide range of GLS. The GLS on the baseline study correlated with the LVEF at the time of follow-up (r=0.33, p<0.001). The likelihood of having an LVEF >50% on follow-up increased by 24% for each point increase in absolute GLS on the baseline study (OR 1.24, p=0.001). An abnormal GLS (≤ 16%) at baseline had a sensitivity of 88%, a specificity of 46%, and an accuracy of 0.67 (p<0.001) as a predictor of a decrease in LVEF > 5% during follow up. A normal GLS (> 16%) on the baseline study had a sensitivity of 47%, a specificity of 83% and an accuracy of 0.65 (p=0.002) for predicting a stable LVEF (−5 to 5 %) on follow-up.
Conclusions
In patients with a recovered LVEF, an abnormal GLS predicts the likelihood of having a decrease LVEF during follow-up, whereas a normal GLS predicts the likelihood of stable LVEF during recovery.
The sensitivity of fragmented QRS in left precordial leads for LVA was only 50%, whereas the specificity was 94.5%. It has a relatively low to moderate positive predictive value and high negative predictive value.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.